P14.27 Pathogenic Genomic Alterations of CDKN2A Predict Immunotherapy Resistance in NSCLC

Authors: Gutiontov, S., Turchan, W., Rouhani, S., Chervin, C. Soto, Segal, J., Bestvina, C., Donington, J., Hoffman, P., Chmura, S., Connell, P., Juloori, A., Malik, R., Ferguson, M., Patel, J., Vokes, E., Weichselbaum, R., Pitroda, S.

Source: In Journal of Thoracic Oncology March 2021 16(3) Supplement:S341-S342